Feasibility assessment of cerebrospinal fluid from HIV-1-infected children for HIV proviral DNA and monocyte chemoattractant protein 1 alleles

Journal of Investigative Medicine

Volumn 54, Issue 8, 2006, Pages 468-472

  Shiramizu, Bruce ^a,b   Lau, Emily ^a   Tamamoto, Alyson ^a   Uniatowski, Justin ^a   Troelstrup, David ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b Young Bldg   (United States)

Author keywords

Cerebrospinal fluid; HIV DNA; HIV 1 associated encephalopathy; Monocyte chemoattractant protein 1

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; BRAIN DISEASE; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; PROVIRUS; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS MUTANT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33846404101     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/6650.2006.06007     Document Type: Article

References (17)

1. Cooper ER, Hanson C, Diaz C, et al. Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection. Women and Infants Transmission Study Group. J Pediatr 1998;132:808-12.
2. Lobato MN, Caldwell MB, Ng P, et al. Encephalopathy in children with perinatally acquired human immunodeficiency virus infection. Pediatric Spectrum of Disease Clinical Consortium. J Pediatr 1995;126(5 Pt 1):710-5.
3. McArthur JC, McClernon DR, Cronin MF, et al. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol 1997;42:689-98.
4. Brew BJ, Pemberton L, Cunningham P, et al. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis 1997;175:963-6.
5. Sei S, Stewart SK, Farley M, et al. Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy. J Infect Dis 1996;174:1200-6.
6. Crowe S, Zhu T, Muller WA. The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J Leukoc Biol 2003;74:635-41.
7. Fischer-Smith T, Croul S, Sverstiuk AE, et al. CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol 2001;7:528-41.
8. Rouzioux C, Hubert JB, Burgard M, et al. Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts. J Infect Dis 2005;192:46-55.
9. Kelder W, McArthur JC, Nance-Sproson T, et al. Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol 1998;44:831-5.
10. Gonzalez E, Rovin BH, Sen L, et al. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A 2002;99:13795-800.
11. Shiramizu B, Gartner S, Williams A, et al. Circulating proviral HIV DNA and HIV-associated dementia. AIDS 2005;19:45-52.
12. Raskino C, Pearson DA, Baker CJ, et al. Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviral regimens. Pediatric AIDS Clinical Trials Group 152 Study Team. Pediatrics 1999;104:e32.
13. Moss HA, Wolters PL, Brouwers P, et al. Impairment of expressive behavior in pediatric HIV-infected patients with evidence of CNS disease. J Pediatr Psychol 1996;21:379-400.
14. Knight WG, Mellins CA, Levenson RL Jr, et al. Brief report: effects of pediatric HIV infection on mental and psychomotor development. J Pediatr Psychol 2000;25:583-7.
15. McCoig C, Castrejon MM, Saavedra-Lozano J, et al. Cerebrospinal fluid and plasma concentrations of proinflammatory mediators in human immunodeficiency virus-infected children. Pediatr Infect Dis J 2004;23:114-8.
16. Gallo P, Laverda AM, De Rossi A, et al. Immunological markers in the cerebrospinal fluid of HIV-1-infected children. Acta Paediatr Scand 1991;80:659-66.
17. Press R, Pashenkov M, Jin JP, et al. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Clin Immunol 2003;23:259-67.